270 related articles for article (PubMed ID: 24310606)
1. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.
Xiong L; Wen Y; Miao X; Yang Z
Cell Tissue Res; 2014 Feb; 355(2):365-74. PubMed ID: 24310606
[TBL] [Abstract][Full Text] [Related]
2. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma.
Wang N; Xiang X; Chen K; Liu P; Zhu A
Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108
[TBL] [Abstract][Full Text] [Related]
3. CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
Cao L; Bridle KR; Shrestha R; Prithviraj P; Crawford DHG; Jayachandran A
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163489
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of LncRNA-ROR predicts a poor outcome in gallbladder cancer patients and promotes the tumor cells proliferation, migration, and invasion.
Wang SH; Zhang MD; Wu XC; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Sep; 37(9):12867-12875. PubMed ID: 27449039
[TBL] [Abstract][Full Text] [Related]
5. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mTOR pathway attenuates migration and invasion of gallbladder cancer via EMT inhibition.
Zong H; Yin B; Zhou H; Cai D; Ma B; Xiang Y
Mol Biol Rep; 2014 Jul; 41(7):4507-12. PubMed ID: 24623408
[TBL] [Abstract][Full Text] [Related]
7. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
[TBL] [Abstract][Full Text] [Related]
8. MiR-20a triggers metastasis of gallbladder carcinoma.
Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of desmoglein 2 promotes EMT progression in gallbladder cancer.
Wang L; Lv Y; Li J; Nan Y; Piao L; Liang Z
Histol Histopathol; 2023 Apr; 38(4):467-474. PubMed ID: 36259602
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-β1 induces epithelial-mesenchymal transition and integrin α3β1-mediated cell migration of HSC-4 human squamous cell carcinoma cells through Slug.
Saito D; Kyakumoto S; Chosa N; Ibi M; Takahashi N; Okubo N; Sawada S; Ishisaki A; Kamo M
J Biochem; 2013 Mar; 153(3):303-15. PubMed ID: 23248240
[TBL] [Abstract][Full Text] [Related]
11. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
[TBL] [Abstract][Full Text] [Related]
12. The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer.
Li W; Yan P; Meng X; Zhang J; Yang Y
Cell Signal; 2021 Apr; 80():109887. PubMed ID: 33340658
[TBL] [Abstract][Full Text] [Related]
13. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Zhu J; Wen K
Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-related receptor-α promotes gallbladder cancer development by enhancing the transcription of Nectin-4.
Wang L; Yang M; Guo X; Yang Z; Liu S; Ji Y; Jin H
Cancer Sci; 2020 May; 111(5):1514-1527. PubMed ID: 32030850
[TBL] [Abstract][Full Text] [Related]
16. NT5E inhibition suppresses the growth of sunitinib-resistant cells and EMT course and AKT/GSK-3β signaling pathway in renal cell cancer.
Peng D; Hu Z; Wei X; Ke X; Shen Y; Zeng X
IUBMB Life; 2019 Jan; 71(1):113-124. PubMed ID: 30281919
[TBL] [Abstract][Full Text] [Related]
17. TGF-β1 facilitates gallbladder carcinoma metastasis by regulating FOXA1 translation efficiency through m
Wu Z; Ke Q; Jiang L; Hong H; Pan W; Chen W; Abudukeremu X; She F; Chen Y
Cell Death Dis; 2024 Jun; 15(6):422. PubMed ID: 38886389
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
19. Loss of NDRG2 promotes epithelial-mesenchymal transition of gallbladder carcinoma cells through MMP-19-mediated Slug expression.
Lee DG; Lee SH; Kim JS; Park J; Cho YL; Kim KS; Jo DY; Song IC; Kim N; Yun HJ; Park YJ; Lee SJ; Lee HG; Bae KH; Lee SC; Shim S; Kim YM; Kwon YG; Kim JM; Lee HJ; Min JK
J Hepatol; 2015 Dec; 63(6):1429-39. PubMed ID: 26292259
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of LncRNA AFAP1-AS1 predicts poor prognosis and promotes cells proliferation and invasion in gallbladder cancer.
Ma F; Wang SH; Cai Q; Zhang MD; Yang Y; Ding J
Biomed Pharmacother; 2016 Dec; 84():1249-1255. PubMed ID: 27810781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]